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Abstract. A decade after the Global Malaria Eradication Program, El Salvador had the highest burden of malaria in
Mesoamerica, with approximately 20% due to Plasmodium falciparum. A resurgence of malaria in the 1970s led El
Salvador to alter its national malaria control strategy. By 1995, El Salvador recorded its last autochthonous P. falciparum
case with fewer than 20 Plasmodium vivax cases annually since 2011. By contrast, its immediate neighbors continue to
have the highest incidences of malaria in the region. We reviewed and evaluated the policies and interventions imple-
mented by the Salvadoran National Malaria Program that likely contributed to this progress toward malaria elimination.
Decentralization of the malaria program, early regional stratification by risk, and data-driven stratum-specific actions
resulted in the timely and targeted allocation of resources for vector control, surveillance, case detection, and treatment.
Weekly reporting by health workers and volunteer collaborators—distributed throughout the country by strata and
informed via the national surveillance system—enabled local malaria teams to provide rapid, adaptive, and focalized
program actions. Sustained investments in surveillance and response have led to a dramatic reduction in local trans-
mission, withmost currentmalaria cases in El Salvador due to importation fromneighboring countries. Additional support
for systematic elimination efforts in neighboring countries would benefit the region andmay be needed for El Salvador to
achieve and maintain malaria elimination. El Salvador’s experience provides a relevant case study that can guide the
application of similar strategies in other countries committed to malaria elimination.
INTRODUCTION
The malaria program in El Salvador is currently in the elim-
ination stage, with only four cases of Plasmodium vivax re-
ported in 2017 among its population of 6.1 million (three
imported, one relapse from 2016) (E. Romero, personal com-
munication). The last case of locally transmitted Plasmodium
falciparum in El Salvador was recorded in 1995 and the last
death from Plasmodium infection occurred in 1984.1 In 1980,
the country contributed 37% of all reported cases in the re-
gion, whereas today it contributes less than 0.1%.2
El Salvador is socioeconomically and epidemiologically
similar (in terms of malaria) to its Mesoamerican border
neighbors: Guatemala, Honduras, and Nicaragua (Table 1).
Key differences include the extent of urbanization and the
overall improved quality of the health system in El Salvador.3
For most of its recent history, patterns of malaria transmission
in thecountrywereanalogous to those in the region: periodsof
decline in incidence followed by periods of resurgence
(Figure 1).2 Beginning in the early 1980s, the number of cases
detected each year began to decline, with a 90% reduction in
cases occurring between 1980 (95,835 reported cases) and
1990 (9,269 reported cases).2 El Salvador continued to reduce
locally acquired cases each year as remaining transmission
foci were cleared, with less than 50 cases annually since
2006; by contrast, its immediate neighbors continue to have
the highest incidences of malaria in the region (Table 2,
Figure 2).2
Lessons learned from El Salvador’s success could guide
malaria elimination strategies in similar countries.We conducted
a review and evaluation of the policies and interventions
implemented by the Salvadoran National Malaria Program
(NMP) to document the progress and assess factors that likely
contributed to this success.
MATERIALS AND METHODS
A systematic approach to the acquisition and analysis of
malaria data and associated public health data was adopted
for this case study.8–10 Data from peer-reviewed and gray
literature—as well as records and documentation from
district-level and national malaria efforts—were obtained
and compiled. Substantial gaps in publicly available litera-
ture and databases were identified. Additional information
detailing specific program strategies, intensity of activities,
treatment guidelines, surveillance systems, stratification
methodologies, and programmatic timelines were compiled
through a series of interviews with local and regional malaria
and vector control experts.
More than 27 experts from 16 international organizations
and national and regional institutions from El Salvador, Gua-
temala, and Honduras were interviewed as part of this research.
These sources were selected based on their expertise and
knowledge of current and historical malaria epidemiology
and government programs in the region. Individual contrib-
utors and their affiliations are listed in the Acknowledgments
section.
Review of the literature and interview data resulted in a
detailed timeline and comparative analysis of possible factors
contributing to the decline in El Salvador’s malaria incidence.
These data also helped generate hypotheses as to which
factors were key contributors to the initial decline and which
factors had contributed to the maintenance of low malaria
incidence.
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The period of rapid decline in El Salvador’s malaria in-
cidence began with a deliberate program transition following
an evaluation of the national malaria control strategy in part-
nership with the Pan American Health Organization (PAHO)
and the United States Centers for Disease Control’s (CDC)
local research station in 1978.11,12 The objective of this
evaluation was to course correct the program after a dra-
matic increase in cases in the late 1970s, a decade after the
global malaria eradication campaign ended.11,12 The evalu-
ation examined data from the previous 7 years of malaria
control activities, developed a mostly geographic stratification
system by malaria risk, and used it to inform program strategy
and resource allocation (E. Romero, personal communication).
The malaria program was decentralized and the new ap-
proach was focused on a well-functioning national surveil-
lance and reporting system, as well as on evidence-based
targeted and timely responses to case detection conducted
weekly. Successful decentralization in El Salvador was facili-
tated through theappointment of local leaderswhowere given
authority to act in real time and who were held responsible for
progress in their respective areas. In 1980, a PAHO evaluator
summarized the new malaria program in El Salvador as a
streamlined process in which “the data are obtained in the
shortest possible timeandadynamic and timely epidemiology
can be conducted in line with the new orientation of the pro-
gram.”13 These concepts were novel at the time of in-
troduction and contributed to reducing malaria incidence
during the 1980s and 1990s.
As casesdropped to very low levels, stratification continued
to drive prioritization of activities; vector control interventions
were increasingly targeted, border surveillance of immigrants
was launched to address imported cases, prompt diagnosis
was maintained, and the surveillance system continued to
track malaria cases.
Malaria risk stratification. The El Salvador NMP worked
to determine the geographic distribution and frequency of
malaria cases, with the objective of stratifying the country by
riskbasedonaltitude and thenumberof bloodsmear–confirmed
cases per 1,000 residents (M. Sauerbrey, unpublished data).14
With the support of United States Agency for International
Development and CDC, epidemiologic stratification was com-
pletedby1979 (Table3,Figure3) and thesedatawere thenused
to transition and target program activities.15 Placement and
number of volunteer collaborators (VCs), number of laboratory
and supervisory personnel, and vector control activities were
all determined by strata, enabling the highest burden areas to
have proportionately higher resources. By 1980, stratification
was an integral part of themalaria strategyandhas remained so
(J. Alemán, personal communication).
Voluntary collaborator network. The VC network, a ver-
tical community malaria platform, was established in El Sal-
vador in the 1950s to test and treat all febrile individuals with
antimalarials. It eventually grew from 79 posts in 1955 to 590
posts in 1959 (M. Sauerbrey, unpublished data). Further ex-
pansion, strengthening, and more effective distribution of the
VC network resulted from the 1978 decentralization and
stratification. Analysis of the annual parasite index (API) and
slide positivity rate data obtained before 1978 indicated that
approximately 80% of the VCs were located in areas with
little or no malaria burden.13 Under stratification, the number
of VCs in each epidemiological stratum was determined
according to malaria risk, with the highest number of VCs
deployed to hyperendemic regions (Table 3). The goal was to
TABLE 1
Similarities and differences between El Salvador and its Mesoamerican neighbors.3–7
Similarities Description El Salvador Guatemala Honduras Nicaragua Mean ± 1 SD
Topographical
and ecological
Low-land coasts with tropical
climate
U U U U –
Interior highlands with temperate
climate




U U U U –
Transmission highest during the
rainy season (May to October)
U U U U –
Socioeconomic Low per capita gross domestic product
(2015) in $US (rank relative to the rest
of North America)
$8,300 (19/23) $7,900 (20/23) $5,000 (21/23) $5,000 (22/23) $6,550 ± $1,797
% Reduction in export of cotton
(1977–1992)
↓95.0% ↓85.7% ↓84.6% ↓98.1% ↓90.9% ± 6.7%
% Increase in population density
(1961–2013)
↑323% ↑291% ↑361% ↑332% ↑327% ± 29%




Total land area (km2) 20,721 107,159 111,890 120,340 90,028 ± 46,525
Socioeconomic Total population density (2014)
(people/km2)
295 149 71 50 141 ± 111
Health indicators Under-five mortality per 1,000 live
births (2013)
16 31 22 24 23 ± 6
Maternal mortality per 100,000 live
births (2015)
54 88 129 150 105 ± 43
SD = standard deviation.
* El Salvador data fall more than one SD away from the mean.
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have one VC for every 600 individuals in the two highest
burden strata.
El Salvador’s VC network was established with strict ex-
pectations: accuracy, timeliness, and respect for authority.16
Volunteer collaborators were traditionally selected by respec-
tedmembers of their own communities, and despite the lack of
monetary compensation, they earned the respect of their peers
and took pride in providing high-quality service (M. Sauerbrey,
personal communication). In many instances, retiring VCs
would pass on their duties to other capable family members
(M. Gavidia, personal communication).17
Volunteer collaborators collected blood smears, provided
presumptive antimalarial treatment of all fever cases, and
kept records of all fever cases and blood smear laboratory
results in the communities they served, although exact
historical responsibilities anddrug regimens remain unclear.
Each VC was assigned a unique identification code so that
reported cases could be tracked by geographic area according
to VC placement, and all case data were reported to the NMP
(E. Romero, personal communication;M. Sauerbrey, unpublished
data). As a component of decentralization, VCs worked collab-
oratively with epidemiology assistants, entomology assistants,
and zonal epidemiological surveillance leads.
Epidemiology assistants would visit each of the VCs in
epidemiological circuits to collect the blood smears and the
surveillance records and to restock VCs with drugs and
blood sampling materials, including microscope slides. En-
tomology assistants were responsible for entomological
data collection and larval control activities (M. Sauerbrey,
personal communication). The objective of the epidemio-
logical circuits was to provide increased oversight to VCs in
areas of highest endemicity. Frequency of epidemiology
assistant visits to VCs varied by region and was determined
by strata: visits were weekly, biweekly, monthly, or every
3 months, depending on the disease burden.14 Epidemiol-
ogy assistants were also responsible for selecting and
training new VCs. Official training varied from 1 to 3 days,
and each VC received a box with the register book and all
necessary supplies as most of them were working out of
their homes (E. Romero, personal communication). In ad-
dition to formal training, nearly all VCs benefitted from
hands-on training from the previous volunteer, who in most
cases was a family member (E. Romero, personal commu-
nication; M. Sauerbrey, personal communication).
The VC network continued to operate and grow through the
period of the civil war, and remains operative to this day as a
core institution of the malaria control efforts in El Salvador. In
2010, 3,246 VCs were reported to be operational.18 As an
example of the continued importance of the VC network,
although only 28% of thick-smear blood slides were taken
by VCs in 2011, they detected 47% of malaria cases.19 In
2011, presumptive treatment was abandoned, and VCs cur-
rently serve a solely diagnostic and surveillance function
(E. Romero, personal communication).
Asmalaria incidence continues to decline,malaria VCshave
been integrated into the overall infectious disease control
programs in El Salvador and, thus, maintain their malaria di-
agnostic and surveillance role while expanding their skillset to
FIGURE 1. Annual malaria cases by country and national benchmarks in the decline of malaria in the region from 1961 to 2017.2
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include other infectious diseases. In 2018, 3,078 integrated
VCs were operational across the country.
Diagnostic laboratory network decentralization. As a
component of the 1978 review, the NMP also recognized the
need to decentralize the decision-making and diagnostic
laboratory system, increasing the number of local laboratories
according to the stratification to shorten slide turnaround time
and empowering local decision-making.
This decentralization occurred between 1978 and 1983.14
The network of regional laboratories expanded largely
along the coast in the highest transmission strata. Whereas
some areas continued to struggle with timely turnaround—
sometimes 30 days in hypoendemic areas—there was on
average a 5-day turnaround in the hyperendemic stratum
throughout the 1980s.12 Slides were prepared and stored
by the VCs and collected by the epidemiology assistants,
who transported slides to the laboratories via motorcycle
(M. Sauerbrey, personal communication). Increased diagnostic
capacity with improved turnaround time enhanced accurate
case management and provided a basis for a strengthened
information system to make decisions.
Surveillance and responses. Beginning in the 1980s, El
Salvador reported several malaria indicators on a weekly
basis. Epidemiological data were entered manually into the
electronic surveillance system to provide the reports via floppy
disk or printouts; these were then accessed and evaluated
weekly by regional and central managers to guide control ef-
forts.20 Weekly reports included number of P. falciparum
cases, P. vivax cases, and blood slides taken by town for the
current week, as well as the number for the prior 4 weeks and
the yearly total (M. Sauerbrey, personal communication).
Zonal epidemiological surveillance leads were responsible
for epidemiological surveillance, administrative tasks, super-
vision, and, most importantly, planning of control interven-
tions at the local level.12 Changes in API compared with the
three previous years in the health catchment areas—down to
the hamlet level (caserı́o in Spanish)—were reviewed to de-
velop the annual operational planning.12 In addition, the epi-
demiological surveillance leads reviewed data from their area
weekly and were empowered to independently respond to
observed changes in a timelymanner with an array of different
interventions, including additional indoor residual spraying,
focal or mass administration of antimalarial drugs, and/or
application of larvicides (Table 4).13
In 1990, the computerized malaria information system was
implemented to address gaps and delays within the manual
FIGURE 2. All reported (imported and autochthonous) malaria cases in El Salvador, 2009–2017 (National Vector Control Program, personal
communication).
TABLE 2
Number of annual reported malaria cases per country in Mesoamerica
Country
Year
1960 1965 1970 1975 1980 1985 1990 1995 2000 2005 2010 2015
El Salvador 10,066 34,070 45,436 83,100 95,835 44,473 9,269 3,364 753 67 24 9
Guatemala 3,387 14,472 11,044 4,979 62,657 54,958 41,711 24,178 53,311 39,571 7,198 5,540
Honduras 5,517 6,952 34,537 30,289 43,010 33,828 53,099 74,346 35,125 16,007 9,745 3,575
Mexico 3,569 10,113 61,158 27,925 25,734 133,698 44,513 7,423 7,390 2,967 1,233 551
Nicaragua 7,528 10,275 27,260 24,692 25,465 15,130 35,785 69,444 23,878 6,642 692 2,307
Costa Rica 2,000 2,563 350 290 376 734 1,151 4,515 1,879 3,541 114 8
Panama 4,464 1,929 4,584 666 304 126 381 730 1,036 3,667 418 562
Belize 196 206 33 90 1,529 2,800 3,033 9,413 1,486 1,549 150 13
Total cases 36,727 80,580 184,402 172,031 254,910 285,747 188,942 193,413 124,858 74,011 19,574 12,565
Contribution (%):
El Salvador
27.41 42.28 24.64 48.31 37.60 15.56 4.91 1.74 0.60 0.09 0.12 0.07
The bolded numbers in each column identify the country with the highest number of cases in a given year.2
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systemandtobetter trackcases,monitor interventioncoverage,
andsupplydataonaweeklybasis (Figure4).AUSAIDevaluation
report described the computerization of the information system
as necessary to increase the system flexibility and capitalize on
recent programsuccesses.21 Later,malaria register databegan
to be reported through the national epidemiological surveil-
lance system, which feeds into the national health information
system (J. Alemán, personal communication).
Since 2010, case investigation is conducted when a new
malaria case is confirmed to prevent further transmission. The
vector control coordinator organizes a responsewith VCs and
local health teams within 24–48 hours of the case confirma-
tion, and focal control actions are implemented (investigat-
ing the case’s household, the neighboring households, and
other places the casemay have visited).14When two ormore
malaria cases are confirmed, the health facility and vector
coordinators follow “outbreak response” guidelines.19 Fur-
ther investigation is conducted to classify cases as either
locally acquired or imported based on travel history.15 Table 5
shows the number of confirmed autochthonous and imported
FIGURE 3. Topographical map of El Salvador detailing the results of the malaria epidemiological stratification (National Vector Control Program,
personal communication). Regions of hyperendemicity (hiperendémica), moderate endemicity (mesoendémica), and hypoendemicity (hipoendémica)
are shown in red, yellow, andgreen, respectively. Areaswith nomalaria endemicity (nomalárica) are shown inwhite. The altitudeabove sea level (altura
sobre el nivel del mar [SNM]), total land area in km2, and population (población) of each region are also indicated in the key below the figure.
TABLE 3
Original CDC-CAR malaria stratification in El Salvador, 197912
Strata Area square kilometer (%) Total cases (%) Number of VC posts (%) Population (%)
Non-malarious (0–19 cases/year)
(> 901 m)
1,888 (9%) 1 382 (13%) 538,979 (10%)
Hypoendemic (20–39 cases/year)
(601–960 m)
11,118 (53%) 3 499 (17%) 3,395,567 (63%)
Mesoendemic (40–59 cases/year)
(301–600 m)
3,216 (15%) 6 656 (23%) 485,081 (9%)
Hyperendemic (> 60 cases/year)
(0–300 m)
4,819 (23%) 90 1,377 (47%) 970,162 (18%)
CDC = Centers for Disease Control; VC = volunteer collaborator.
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malaria cases by year between 2010 and 2017 (E. Romero,
personal communication).2 Of the 14 confirmed P. vivax
malaria cases in 2016, one was imported and the other
13 could not be investigated because of social risk in the
area; of the four P. vivax malaria cases in 2017, three were
imported and one was a relapse in a case from 2016 (Table 5)
(E. Romero, personal communication).2
Casemanagement and change in treatment regimen. In
the early 1980s, El Salvador’s passive case detection (PCD)
system consisted of VCs, health centers, and hospitals, al-
though VCs were the primary source of PCD. Initial treatment
of fever caseswas presumptive and began the day themalaria
blood smear slide was taken; if negative smear results were
received before the treatment coursewas over, treatment was
terminated (J. Alemán, personal communication). In addition,
active case detection occurred during parasitology surveys,
where National Malaria Service workers visited residents in
homes, collected blood smears from each individual in the
home, and provided presumptive treatment to anyone with
recent fever.21 By the late 1980s, these malaria surveys were
being conducted twice each year in selected villages in
high-, moderate-, and low-transmission areas in an effort to
measure changes in malaria prevalence that were not nor-
mally detectable through the passive surveillance system.12 In
1989, VCs were responsible for 70% of all blood samples
taken and 94% of all cases diagnosed; 30% of all blood sam-
ples taken that year resulted from active case detection.12
A 1992 review of the malaria control program activities
found that only 4–6% of people who visited VCs with malaria-
related symptoms were confirmed to have malaria, suggest-
ing that approximately 95% of patients who did not have
malaria received presumptive treatment.2,12 This practice
continues today, and according to the World Malaria Report,
124,743 courses of treatment were prescribed despite only 21
positive cases recorded in 2012.22
Regarding treatment, the NMP transitioned from a 3-day
chloroquine (CQ) plus 14-day primaquine (PQ) treatment
regimen to a5-day treatment regimenof combinedCQ+PQ in
the early 1980s, following a PQ efficacy study conducted in El
Salvador by the CDC-Central American Research station.12,23
The shortened treatment regimen was intended to address
compliance issues of patients not completing the longer
treatment course. The program aimed to have all five doses
supervised, although it is unclear as to what degree this was
completed.
In the early 2010s, following global recommendations and
quality control issues found in locallymanufacturedCQ-PQ, El
Salvador changed the treatment regimen to CQ for 3 days
followed by PQ for 14 days, and the case management
guidelines were changed to treating confirmed cases only
(E. Romero, personal communication; J. Alemán, personal
communication).18 When a case is suspected, a blood smear
is taken and analyzed within 24 hours (in the highest trans-
mission strata).14 When a positive malaria blood smear is
found, the patient must seek treatment from the local health
team or facility (VCs do not provide treatment anymore) and
then undergo follow-up testing (a blood smear taken monthly
for 3months) after treatment to confirmparasite clearance and
conduct surveillance for parasite drug resistance (E. Romero,
personal communication).19
TABLE 4
Interventions applied in combination according to season and local
entomological and epidemiological data in the 1980s13
Targeted at the vector
Entomological surveillance and mapping of breeding sites
Application of larvicides (chemical products) to breeding sites
Intra- and peri-domiciliary ultralow-volume aerial spraying
Indoor residual spraying in areas with no insecticide resistance
Targeted at the individual
Utilization of radical cure for all cases
Focal or mass drug administration to specific populations (coffee
and cotton agricultural workers) or caserı́os
Targeted at the environment and the community
Environmental management to reduce breeding sites (build canals,
weed water streams, etc.)
Behavior change communication and community engagement
FIGURE 4. Electronic scan of a portion of a weekly malaria report computer printout from 1995 (M. Sauerbrey, personal communication). The
location (localidad), currentweek (esta semana), last 4weeks (ultimas four semanas), and cumulative yearly (acumuladoannual) totals are shown for
Plasmodium falciparum (FAL),Plasmodiumvivax (VIV), the numberof positives (POS)determined, and thenumberofmicroscopeslides taken (LAM).
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Environmental management and vector control. The
improvement and maintenance of water management proj-
ects to eliminate breeding sites were also cited as a key
component of El Salvador’s vector control strategy, which
aimed to reducedependenceon vector control through indoor
residual spraying (Figure 5) (M. Sauerbrey, personal commu-
nication).12 In the early 1980s, two large environmental man-
agement projects began in the Department of La Libertad to
limit standingwater of twoestuaries—areaswhere themouths
of rivers entering the Pacific Ocean would close during the
dry season, producing large mosquito breeding sites often
close to large towns (M. Sauerbrey, unpublished data). In
total, there were 10 primary source reduction sites, which were
the products of collaboration between the National Program,
USAID, and PAHO (M. Sauerbrey, personal communication).12
National funding environment. USAID and domestic
funding supported activities during the initial phase until the
early 1990s, with USAID funding and the CDC research sta-
tion’s technical support proving critical to the development
and implementation of the new strategic plan (M. Sauerbrey,
personal communication). However, USAID ceased funding in
1994, leading the national government to increase its financial
support tomaintain ongoing activities (M.Sauerbrey, personal
communication). Starting in 1999, the Ministry of Health dis-
tributed the administrative and financial authority of its health
system, and the NMP was integrated into the larger National
Vector Control Program (E. Romero, personal communica-
tion; C. Avila, personal communication).24 Despite these
structural changes, El Salvador’s malaria activities benefited
from stable domestic financing even as external donors
withdrew their support (Figure 6).2
Furthermore, from 2000 to 2010, as El Salvador achieved
very low and continually declining case numbers, domestic
financing increased slowly; it was not until 2017 that the
government again started receiving external funding for
malaria through theElimination ofMalaria inMesoamerica and
Hispaniola Global Fund regional funding mechanism.25,26
Currently, domestic funding for national vector control priori-
ties is at the discretion of the Vector Control Program director
(E. Romero, personal communication). To date, continued
maintenance of themalaria surveillance system and response
capacity has been a priority. By contrast, funding for malaria
in Guatemala and Honduras has been less predictable
throughout the past three decades.
DISCUSSION
As a model and historic pace-setter, El Salvador offers
many lessons to countries in the Mesoamerican subregion
and beyond. The NMP in El Salvador undertook a major
transition of its program activities in the early 1980s, the key
features of whichwere early stratification, a high coverage of a
malaria-specific VCnetwork, targeted allocation of resources,
and a strong surveillance system guided by the implementa-
tion of a versatile computerized system that allowed precise,
data-informed decision-making. Results from this research
suggest that El Salvador’s early and continued decline in
malaria cases was associated with these interventions and
strategies, which were putatively used earlier and more sys-
tematically than in Guatemala and Honduras. However, it is
probable that socioeconomic factors also played a role. The
dramatic decline in malaria cases in the 1980s and 1990s
coincided with the Salvadoran civil war (1980–1992), land re-
form, and the collapse of the national cotton industry. Despite
potential interruption of program infrastructure, these factors
may have reduced malaria transmission and malaria re-
ceptivity by consolidating the population into urban centers,
curbing general population movement, and reducing the size
of the seasonal cotton workforce at elevated risk of malaria
infection (E. Romero, personal communication).
However, in Guatemala and Honduras, where there was
also a civil war, a cotton industry that collapsed, and an in-
crease in population density (Table 1), malaria has only re-
cently declined (Figure 1). Taken together, these data suggest
that the rapid decline in El Salvador resulted both from NMP
actions and from changes in malaria transmission dynamics
created by changing socioeconomic conditions. After 1980,
El Salvador contributed a continuously decreasing percent-
age of the regional malaria cases even though overall re-
ported case numbers remained high. Persistent high levels
of reported cases among El Salvador’s closest neighbors,
TABLE 5
Classification of malaria cases in El Salvador, 2011–2017 (National
Vector Control Program, personal communication)
Vector 2011 2012 2013 2014 2015 2016 2017
Plasmodium vivax 15 19 7 8 9 14 4
Autochthonous 9 13 6 6 3 13* 1†
Imported 6 6 1 2 6 1 3
Plasmodium falciparum 13 3 0 0 0 0 0
Total recorded cases 25 21 7 8 9 14 4
*Not investigated.
†Relapse.
FIGURE 5. Reduction in the number of households treated with indoor residual spraying as a result of stratification, declining malaria incidence,
and environmental projects to improve water management.2
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Guatemala and Honduras, relative to the region as a whole
support the assertion that programmatic actions in El Salva-
dor had a profound effect on malaria incidence and that
the decrease cannot be solely attributed to economic devel-
opment, climate, or ecology. In addition to its smaller size
and more dense population, El Salvador’s malaria program
benefitted from strong national leadership that ensured
sustained financing for malaria control and technical assis-
tance through the in-country presence of the CDC regional
research station, followed by a large USAID assistance pro-
ject and high coverage of the motivated VC network in a ver-
tical program. As stated by Randall M. Packard, “the success
of malaria control in El Salvador during the 1980s needs to be
viewed as the result of an efficiently designed malaria control
FIGURE 6. Financing and malaria cases in El Salvador, Guatemala, and Honduras, 1960–2016.2
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program operating within a favorable social and economic
environment.”27
El Salvador’s multi-decade malaria effort is an impressive
success story. It demonstrates that targeted, evidence-
based action carried out through a highly organized (yet
decentralized) and sufficiently funded program is a successful
infectious disease elimination model that other countries or
regionsmay choose to implement. Currently, the importation
and spread of malaria from neighboring countries, risk of
waning financial support, and loss of programmatic exper-
tise as malaria experts retire and institutional memory and
capacity are lost pose the greatest potential challenges for
El Salvador to reach the national goal of elimination by 2020.
Additional support for systematic elimination efforts in neigh-
boring countries would benefit the region and may be needed
for El Salvador to achieve and maintain malaria elimination.
Lessons learned from El Salvador’s success can help guide
malaria elimination strategies in the region and beyond.
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